Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05016505 · ClinicalTrials.gov registry record · NA
Supporting Smoke-Free Policy Compliance in Public Housing
A NA study, sponsored by Columbia University.
- Completed
- Registry status
- NA
- Development phase
- 405
- Enrollment target
NCT05016505: Completed NA study, sponsored by Columbia University.
NCT05016505 is a NA study that has completed, run by Columbia University. The registered enrollment target is 405 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (71% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05016505, a NA study, has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- NA
- Development phase
- 405 participants
- Enrollment target
Study Summary
This project seeks to determine the effectiveness of two types of interventions to reduce exposure to secondhand smoke in residential buildings. One intervention is geared toward all building residents (resident endorsement) and the other targets smokers (smoking reduction via relocation and reduction in personal smoking/cessation) with the goal of reducing personal smoking and secondhand smoke exposure.
Primary Outcome
Self-reported average number of cigarettes smoked per day among smokers
Interventions
- BEHAVIORAL Reduction (relocation and reduction of personal smoking) and cessation
- BEHAVIORAL Resident Endorsement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 405 participants |
| Start Date | 2022-02-03 |
| Est. Completion | 2025-07-31 |
| Phase | NA |
What the finished NCT05016505 record still lists
NCT05016505 is an interventional study that assigns participants to a tested intervention. The registered 405 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (71% lower).
The record links to 0 conditions, and to 2 interventions - of which Reduction (relocation and reduction of personal smoking) and cessation is the first listed.
NCT05016505 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05016505 about?
NCT05016505 is a clinical study titled "Supporting Smoke-Free Policy Compliance in Public Housing". This project seeks to determine the effectiveness of two types of interventions to reduce exposure to secondhand smoke in residential buildings. One intervention is geared toward all building residents (resident endorsement) and the other targets smokers (smoking reduction via relocation and reducti...
What is the current status of trial NCT05016505?
This trial is currently completed. It is a NA study. The enrollment target is 405 participants. The study started on 2022-02-03. Estimated completion is 2025-07-31.
What interventions are being tested in trial NCT05016505?
The interventions under investigation include: Reduction (relocation and reduction of personal smoking) and cessation (BEHAVIORAL), Resident Endorsement (BEHAVIORAL).
Who is sponsoring clinical trial NCT05016505?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05016505's enrollment target sits among peer trials
405 243rd of 2000 higher than 1,757 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05576350 · 405 participants · NA
TRAC-ER Intervention to Reduce Risky Alcohol Use and HIV Risk
- NCT07066657 · 405 participants · Phase 1
A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors
- NCT06223360 · 406 participants · Phase 2
A Trial to Evaluate the Safety and Efficacy of Benfotiamine in Patients With Early Alzheimer's Disease (BenfoTeam)
- NCT06411769 · 406 participants · NA
Evidence-based Intervention to Improve Walking Engagement in El Paso, Texas
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI